{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:22:50Z","timestamp":1789168970122,"version":"build-2803163510"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>\n                    Psilocybin is found in a family of mushrooms commonly known as Psilocybe. We aimed to study the antinociceptive efficacy of psilocybin using formalin-induced noxious stimuli, a model that comprises both acute and persistent pain in rats. Adult male Sprague\u2013Dawley rats were used. Psilocybin (0.1, 0.3, and 1\u2005mg\/kg, IP) or vehicle was administered, and 6\u2005h later, formalin (5%, 50\u2005\u00b5L, subcutaneous) was injected into the hindpaw, and the number of flinches and time spent for licking were recorded for 0\u201310 and 20\u201360\u2005min for acute and tonic phases, respectively. Another set of rats was used to examine if the antinociceptive effect of psilocybin is via 5-hydroxytryptamine\n                    <jats:sub>2a<\/jats:sub>\n                    receptor (5-HT\n                    <jats:sub>2A<\/jats:sub>\n                    R). For this aim, rats were pretreated with volinanserin (0.1\u2005mg\/kg, highly selective 5-HT\n                    <jats:sub>2A<\/jats:sub>\n                    R antagonist) or vehicle 30\u2005min before psilocybin (0.3\u2005mg\/kg). Six hours later, formalin was injected, and the number of flinches and time spent for licking were recorded. Psilocybin (0.1 and 0.3\u2005mg\/kg) significantly reduced flinching and licking behaviors in both acute and late pain phases and pretreatment with volinanserin blocked the antinociceptive effect of psilocybin. Our results suggest that psilocybin produces an analgesic effect for acute and tonic inflammatory pain, at least in part, by activating 5-HT\n                    <jats:sub>2A<\/jats:sub>\n                    R.\n                  <\/jats:p>","DOI":"10.1097\/fbp.0000000000000856","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T10:00:11Z","timestamp":1759140011000},"page":"618-623","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Psilocybin inhibits formalin-induced nociception through 5-hydroxytryptamine 2A receptor in rats"],"prefix":"10.1097","volume":"36","author":[{"given":"Saadet","family":"Inan","sequence":"first","affiliation":[{"name":"Center for Substance Abuse Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Morris","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Rawls","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research"},{"name":"Department of Neural Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Daws","sequence":"additional","affiliation":[{"name":"Center for Substance Abuse Research"},{"name":"Department of Neural Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"R1-20251107","doi-asserted-by":"crossref","first-page":"1527783","DOI":"10.3389\/fpain.2025.1527783","article-title":"Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: an open-label pilot clinical trial.","volume":"6","author":"Aday","year":"2025","journal-title":"Front Pain Res (Lausanne)"},{"key":"R2-20251107","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/jm000339w","article-title":"Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.","volume":"43","author":"Blair","year":"2000","journal-title":"J Med Chem"},{"key":"R3-20251107","doi-asserted-by":"crossref","first-page":"111347","DOI":"10.1016\/j.pnpbp.2025.111347","article-title":"The effect of low-dose psilocybin on brain neurotransmission and rat behavior.","volume":"138","author":"Bysiek","year":"2025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R4-20251107","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1111\/bph.14769","article-title":"Opioid-sparing effects of cannabinoids on morphine analgesia: participation of CB1 and CB2 receptors.","volume":"176","author":"Chen","year":"2019","journal-title":"Br J Pharmacol"},{"key":"R5-20251107","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neuroimage.2013.02.046","article-title":"Systemic inflammation alters central 5-HT function as determined by pharmacological MRI.","volume":"75","author":"Couch","year":"2013","journal-title":"Neuroimage"},{"key":"R6-20251107","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1016\/S0024-3205(02)02102-1","article-title":"Antipruritic and antihyperalgesic actions of loperamide and analogs.","volume":"71","author":"DeHaven-Hudkins","year":"2002","journal-title":"Life Sci"},{"key":"R7-20251107","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1017\/S1092852922000888","article-title":"Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.","volume":"28","author":"Dodd","year":"2023","journal-title":"CNS Spectr"},{"key":"R8-20251107","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jpain.2022.05.003","article-title":"If the doors of perception were cleansed, would chronic pain be relieved? Evaluating the benefits and risks of psychedelics.","volume":"23","author":"Dworkin","year":"2022","journal-title":"J Pain"},{"key":"R9-20251107","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/09540261.2018.1481827","article-title":"Psychedelics as anti-inflammatory agents.","volume":"30","author":"Flanagan","year":"2018","journal-title":"Int Rev Psychiatry"},{"key":"R10-20251107","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/s41380-024-02788-y","article-title":"Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats.","volume":"30","author":"Floris","year":"2025","journal-title":"Mol Psychiatry"},{"key":"R11-20251107","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1177\/20494637251319497","article-title":"Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use.","volume":"19","author":"Glynos","year":"2025","journal-title":"Br J Pain"},{"key":"R12-20251107","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00213-013-3006-z","article-title":"Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.","volume":"227","author":"Halberstadt","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"key":"R13-20251107","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1177\/0269881110388326","article-title":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.","volume":"25","author":"Halberstadt","year":"2011","journal-title":"J Psychopharmacol"},{"key":"R14-20251107","doi-asserted-by":"crossref","first-page":"107933","DOI":"10.1016\/j.neuropharm.2019.107933","article-title":"Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.","volume":"167","author":"Halberstadt","year":"2020","journal-title":"Neuropharmacology"},{"key":"R15-20251107","first-page":"164P","article-title":"Afferent C-fiber and A-delta activity in models of inflammation.","volume":"90","author":"Heapy","year":"1987","journal-title":"Br J Pharmacol"},{"key":"R16-20251107","doi-asserted-by":"crossref","first-page":"148310","DOI":"10.1016\/j.brainres.2023.148310","article-title":"Cyanidin prevents MDPV withdrawal-induced anxiety-like effects and dysregulation of cytokine systems in rats.","volume":"1806","author":"Inan","year":"2023","journal-title":"Brain Res"},{"key":"R17-20251107","doi-asserted-by":"crossref","first-page":"110571","DOI":"10.1016\/j.neuropharm.2025.110571","article-title":"Blocking IL-17A inhibits methamphetamine-induced hyperlocomotion and conditioned place preference and prevents methamphetamine abstinence-induced depression-like behaviors in mice.","volume":"278","author":"Inan","year":"2025","journal-title":"Neuropharmacology"},{"key":"R18-20251107","first-page":"S0896-6273(25)00470-2","article-title":"The polypharmacology of psychedelics reveals multiple targets for potential therapeutics.","volume":"15","author":"Jain","year":"2025","journal-title":"Neuron"},{"key":"R19-20251107","doi-asserted-by":"crossref","first-page":"e9421","DOI":"10.1002\/ccr3.9421","article-title":"Refractory CRPS pain treated with psilocybin: a case report.","volume":"12","author":"Jevotovsky","year":"2024","journal-title":"Clin Case Rep"},{"key":"R20-20251107","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.cell.2020.08.024","article-title":"Structure of a hallucinogen-activated Gq-coupled 5-HT(2A) serotonin receptor.","volume":"182","author":"Kim","year":"2020","journal-title":"Cell"},{"key":"R21-20251107","doi-asserted-by":"crossref","first-page":"R1282","DOI":"10.1016\/j.cub.2023.10.016","article-title":"Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain.","volume":"33","author":"Kolbman","year":"2023","journal-title":"Curr Biol"},{"key":"R22-20251107","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/papr.13203","article-title":"Are psychedelics the answer to chronic pain: a review of current literature.","volume":"23","author":"Kooijman","year":"2023","journal-title":"Pain Pract"},{"key":"R23-20251107","doi-asserted-by":"crossref","first-page":"107699","DOI":"10.1016\/j.phrs.2025.107699","article-title":"IUPHAR article: psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic pain.","volume":"215","author":"Koseli","year":"2025","journal-title":"Pharmacol Res"},{"key":"R24-20251107","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1747-0285.2010.01011.x","article-title":"Structural combination of established 5-HT(2A) receptor ligands: new aspects of the binding mode.","volume":"76","author":"Kramer","year":"2010","journal-title":"Chem Biol Drug Des"},{"key":"R25-20251107","doi-asserted-by":"crossref","first-page":"242","DOI":"10.3389\/fnbeh.2018.00242","article-title":"Validating rat model of empathy for pain: effects of pain expressions in social partners.","volume":"12","author":"Li","year":"2018","journal-title":"Front Behav Neurosci"},{"key":"R26-20251107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/7854_2017_478","article-title":"Hallucinogens and serotonin 5-HT(2A) receptor-mediated signaling pathways.","volume":"36","author":"L\u00f3pez-Gim\u00e9nez","year":"2018","journal-title":"Curr Top Behav Neurosci"},{"key":"R27-20251107","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/j.pain.0000000000002778","article-title":"Microdosing psilocybin for chronic pain: a case series.","volume":"164","author":"Lyes","year":"2023","journal-title":"Pain"},{"key":"R28-20251107","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/s41593-023-01316-5","article-title":"Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.","volume":"26","author":"Moliner","year":"2023","journal-title":"Nat Neurosci"},{"key":"R29-20251107","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0160-5402(88)90078-2","article-title":"Methodological refinements to the mouse paw formalin test. An animal model of tonic pain.","volume":"20","author":"Murray","year":"1988","journal-title":"J Pharmacol Methods"},{"key":"R30-20251107","doi-asserted-by":"crossref","first-page":"e75426","DOI":"10.1371\/journal.pone.0075426","article-title":"Serotonin 5-HT2A receptor activation blocks TNF-\u03b1 mediated inflammation in vivo.","volume":"8","author":"Nau","year":"2013","journal-title":"PLoS One"},{"key":"R31-20251107","doi-asserted-by":"crossref","first-page":"L191","DOI":"10.1152\/ajplung.00138.2013","article-title":"Serotonin 5-HT\u2082 receptor activation prevents allergic asthma in a mouse model.","volume":"308","author":"Nau","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"R32-20251107","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jpba.2013.10.017","article-title":"Development of novel chiral capillary electrophoresis methods for the serotonin receptor (5-HT2A) antagonist MDL 100,907 (volinanserin) and for its key intermediate compound.","volume":"88","author":"N\u00e9meth","year":"2014","journal-title":"J Pharm Biomed Anal"},{"key":"R33-20251107","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/a-1095-5418","article-title":"Involvement of NO in antinociception of NSAIDS in murine formalin hind paw assay.","volume":"70","author":"Noriega","year":"2020","journal-title":"Drug Res (Stuttg)"},{"key":"R34-20251107","first-page":"123","article-title":"M-100907 (Aventis).","volume":"2","author":"de Paulis","year":"2001","journal-title":"Curr Opin Investig Drugs"},{"key":"R35-20251107","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.euroneuro.2016.05.001","article-title":"Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.","volume":"26","author":"Rickli","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"key":"R36-20251107","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s11916-022-01063-5","article-title":"Self-reported efficacy of treatments in cluster headache: a systematic review of survey studies.","volume":"26","author":"Rusanen","year":"2022","journal-title":"Curr Pain Headache Rep"},{"key":"R37-20251107","doi-asserted-by":"crossref","first-page":"109166","DOI":"10.1016\/j.neuropharm.2022.109166","article-title":"Psychedelics as preventive treatment in headache and chronic pain disorders.","volume":"215","author":"Schindler","year":"2022","journal-title":"Neuropharmacology"},{"key":"R38-20251107","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/head.14420","article-title":"Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: results from a randomized, double-blind, placebo-controlled trial.","volume":"62","author":"Schindler","year":"2022","journal-title":"Headache"},{"key":"R39-20251107","doi-asserted-by":"crossref","first-page":"bqae083","DOI":"10.1210\/endocr\/bqae083","article-title":"Potential differences in psychedelic actions based on biological sex.","volume":"165","author":"Shadani","year":"2024","journal-title":"Endocrinology"},{"key":"R40-20251107","doi-asserted-by":"crossref","first-page":"14148","DOI":"10.3390\/ijms232214148","article-title":"Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: translational implications.","volume":"23","author":"Shahar","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R41-20251107","doi-asserted-by":"crossref","first-page":"727117","DOI":"10.3389\/fpsyt.2021.727117","article-title":"Psychedelics and other psychoplastogens for treating mental illness.","volume":"12","author":"Vargas","year":"2021","journal-title":"Front Psychiatry"},{"key":"R42-20251107","doi-asserted-by":"crossref","first-page":"S100","DOI":"10.1038\/d41586-022-02878-3","article-title":"The psychedelic remedy for chronic pain.","volume":"609","author":"Watson","year":"2022","journal-title":"Nature"},{"key":"R43-20251107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/BF02244551","article-title":"Standardization of the rat paw formalin test for the evaluation of analgesics.","volume":"104","author":"Wheeler-Aceto","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"R44-20251107","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0304-3959(90)90073-M","article-title":"The rat paw formalin test: comparison of noxious agents.","volume":"40","author":"Wheeler-Aceto","year":"1990","journal-title":"Pain"},{"key":"R45-20251107","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.brainres.2008.02.049","article-title":"Involvement of serotonin 2A receptors in the analgesic effect of tramadol in mono-arthritic rats.","volume":"1210","author":"Xie","year":"2008","journal-title":"Brain Res"},{"key":"R46-20251107","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.108.143461","article-title":"Serotonin 5-hydroxytryptamine(2A) receptor activation suppresses tumor necrosis factor-alpha-induced inflammation with extraordinary potency.","volume":"327","author":"Yu","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"R47-20251107","doi-asserted-by":"crossref","first-page":"17448069221087583","DOI":"10.1177\/17448069221087583","article-title":"Spinal 5-HT2A receptor is involved in electroacupuncture inhibition of chronic pain.","volume":"18","author":"Yuan","year":"2022","journal-title":"Mol Pain"},{"key":"R48-20251107","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0304-3959(02)00026-X","article-title":"Expression of 5-HT1A receptor mRNA in rat lumbar spinal dorsal horn neurons after peripheral inflammation.","volume":"98","author":"Zhang","year":"2001","journal-title":"Pain"}],"container-title":["Behavioural Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T10:02:01Z","timestamp":1762509721000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/FBP.0000000000000856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":48,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/fbp.0000000000000856","relation":{},"ISSN":["0955-8810","1473-5849"],"issn-type":[{"value":"0955-8810","type":"print"},{"value":"1473-5849","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"2025-07-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}